OPCH

+ Watchlist + Portfolio

Option Care Health, Inc.

GridBrain — Sign in

GridSentinel — Sign in

GridAegis — Sign in

Key Metrics

Previous Close: $23.35
52-Week Range: $18.01 – $36.80
Market Cap: $3.52B
P/E (TTM): 17.80
EPS (TTM): 1.32
Dividend Yield: —

Advanced Metrics

Price/Book: 2.79
PEG Ratio: 1.25
Return on Equity: 16.00%
Return on Assets: 6.17%
Gross Margin: 19.06%
Operating Margin: 5.90%
Profit Margin: 3.68%
Current Ratio: 1.47
Debt/Equity: 1.01
Total Debt: $1.27B
Free Cash Flow: $256.07M
Revenue Growth: 1.90%
Earnings Growth: 12.90%
Enterprise Value: $4.57B

OPCH Income statement, annual periods, in USD
USD	FY2022	FY2023	FY2024	FY2025
Revenue	$3.94B	$4.30B	$5.00B	$5.65B
Cost of Revenue	$3.08B	$3.32B	$3.99B	$4.56B
Gross Profit	$866.92M	$981.22M	$1.01B	$1.09B
Selling, General & Admin	$566.12M	$607.43M	$630.25M	$682.45M
Operating Expenses	$626.69M	$666.63M	$691.16M	$749.99M
Operating Income	$240.23M	$314.60M	$321.83M	$337.91M
EBITDA	$325.01M	$472.19M	$396.13M	$408.15M
Pretax Income	$205.77M	$358.74M	$283.60M	$282.90M
Income Tax	$55.21M	$91.65M	$71.78M	$75.31M
Net Income	$150.56M	$267.09M	$211.82M	$207.59M
Diluted EPS	0.83	1.48	1.23	1.27
Diluted Shares	182.07M	180.38M	172.84M	163.37M

OPCH Balance Sheet statement, annual periods, in USD
USD	FY2022	FY2023	FY2024	FY2025
Cash & Equivalents	$294.19M	$343.85M	$412.56M	$232.62M
Receivables	$377.54M	$377.66M	$409.73M	$473.57M
Inventory	$224.28M	$274.00M	$388.13M	$471.15M
Current Assets	$994.34M	$1.09B	$1.32B	$1.26B
Total Assets	$3.11B	$3.22B	$3.42B	$3.46B
Current Liabilities	$565.35M	$618.31M	$780.15M	$829.35M
Long-Term Debt	$1.06B	$1.06B	$1.10B	$1.15B
Total Debt	$1.16B	$1.17B	$1.22B	$1.27B
Total Liabilities	$1.73B	$1.80B	$2.02B	$2.13B
Retained Earnings	$190.42M	$457.51M	$669.34M	$876.92M
Shareholders' Equity	$1.39B	$1.42B	$1.40B	$1.33B
Working Capital	$428.99M	$475.95M	$542.48M	$435.62M
Net Debt	$770.02M	$718.80M	$698.59M	$928.21M

OPCH Cash Flow statement, annual periods, in USD
USD	FY2022	FY2023	FY2024	FY2025
Operating Cash Flow	$267.55M	$371.30M	$323.39M	$258.45M
Capital Expenditure	-$35.36M	-$41.87M	-$35.61M	-$41.31M
Free Cash Flow	$232.19M	$329.43M	$287.79M	$217.14M
Depreciation & Amortisation	$65.43M	$62.20M	$63.50M	$70.69M
Stock-Based Compensation	$16.78M	$30.48M	$36.14M	$39.96M
Investing Cash Flow	-$108.05M	-$56.51M	-$36.47M	-$161.08M
Financing Cash Flow	$15.27M	-$265.13M	-$218.21M	-$277.31M
Share Repurchases	$0.00	-$250.26M	-$252.73M	-$309.95M
Net Change in Cash	$174.76M	$49.66M	$68.72M	-$179.94M

OPCH Income statement, quarterly periods, in USD
USD	Q2 2025	Q3 2025	Q4 2025	Q1 2026	Q2 2026
Revenue	$1.42B	$1.44B	$1.47B	$1.35B	$1.44B
Cost of Revenue	$1.15B	$1.16B	$1.18B	$1.09B	$1.18B
Gross Profit	$269.04M	$272.90M	$282.90M	$262.01M	$267.25M
Selling, General & Admin	$170.09M	$172.10M	$172.14M	$174.56M	$164.66M
Operating Expenses	$186.33M	$188.40M	$191.40M	$189.47M	$182.11M
Operating Income	$82.71M	$84.51M	$91.50M	$72.55M	$85.14M
EBITDA	$100.26M	$100.16M	$114.57M	$89.96M	$106.39M
Pretax Income	$68.86M	$68.97M	$81.52M	$61.00M	$73.99M
Income Tax	$18.34M	$17.15M	$23.01M	$15.66M	$20.07M
Net Income	$50.52M	$51.82M	$58.50M	$45.34M	$53.91M
Diluted EPS	0.31	0.32	0.37	0.29	0.35
Diluted Shares	164.13M	163.09M	159.83M	158.21M	153.49M

OPCH Balance Sheet statement, quarterly periods, in USD
USD	Q2 2025	Q3 2025	Q4 2025	Q1 2026	Q2 2026
Cash & Equivalents	$198.82M	$309.82M	$232.62M	$177.32M	$193.77M
Receivables	$481.25M	$474.50M	$473.57M	$516.44M	$549.21M
Inventory	$403.54M	$415.72M	$471.15M	$415.69M	$399.61M
Current Assets	$1.18B	$1.28B	$1.26B	$1.20B	$1.20B
Total Assets	$3.38B	$3.48B	$3.46B	$3.38B	$3.38B
Current Liabilities	$773.62M	$823.91M	$829.35M	$729.75M	$819.48M
Long-Term Debt	$1.10B	$1.16B	$1.15B	$1.15B	$1.15B
Total Debt	$1.23B	$1.28B	$1.27B	$1.27B	$1.27B
Total Liabilities	$2.02B	$2.12B	$2.13B	$2.03B	$2.12B
Retained Earnings	$766.60M	$818.42M	$876.92M	$922.26M	$976.18M
Shareholders' Equity	$1.36B	$1.36B	$1.33B	$1.35B	$1.26B
Working Capital	$401.61M	$458.86M	$435.62M	$465.36M	$381.12M
Net Debt	$911.39M	$852.01M	$928.21M	$982.50M	$965.05M

OPCH Cash Flow statement, quarterly periods, in USD
USD	Q2 2025	Q3 2025	Q4 2025	Q1 2026	Q2 2026
Operating Cash Flow	$90.33M	$139.44M	$35.89M	-$12.11M	$183.59M
Capital Expenditure	-$9.10M	-$9.20M	-$13.65M	-$9.05M	-$11.08M
Free Cash Flow	$81.24M	$130.24M	$22.25M	-$21.16M	$172.52M
Depreciation & Amortisation	$16.95M	$17.05M	$20.32M	$15.65M	$18.38M
Stock-Based Compensation	$10.71M	$11.13M	$9.32M	$10.20M	$8.38M
Investing Cash Flow	-$9.02M	-$11.72M	-$13.65M	-$9.32M	-$11.68M
Financing Cash Flow	-$53.87M	-$16.71M	-$99.44M	-$33.87M	-$155.47M
Share Repurchases	-$52.21M	-$62.46M	-$95.06M	-$17.54M	-$153.01M
Net Change in Cash	$27.45M	$111.00M	-$77.20M	-$55.30M	$16.45M

Market Snapshot

About

Option Care Health is the largest independent provider of home and alternate site infusion services in the United States, delivering complex medications and therapies outside hospital settings.